FDA approves Talicia for H. pylori infection in adults

The FDA approved Talicia for the treatment of Helicobacter pylori infection in adults, manufacturer Redhill Biopharma announced.H. pylori infection is the major cause of peptic ulcers and gastritis and is associated with an up to six-fold increased risk for gastric cancer and mucosal associated-lymphoid-type lymphoma, according to the CDC.Redhill said Talicia (omeprazole magnesium, amoxicillin and rifabutin) is the first and only FDA-approved rifabutin-based H. pylori therapy and is designed to address the “high and growing bacterial resistance and diminished efficacy ofRead More

Share on facebook
Share on twitter
Share on linkedin